The decision follows a pattern of policy shifts, including the rollback of COVID-19 recommendations and cancellation of mRNA funding.
The U.S. Food and Drug Administration has refused to consider Moderna’s application for a new flu vaccine, which utilizes ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results